Peter Kash, Ed.D, MBA has been in the biotechnology field for over 30 years helping fund more than a dozen biopharmaceutical companies. Currently, he is managing director at Castle Hill Capital Partners and vice-chairman of TargImmune Therapeutics AG.
Besides a BS in Management Science and an MBA in Finance and International Banking, he also holds a Doctorate in Education from Azrieli School of Yeshiva University. He has served as an adjunct professor of Entrepreneurship at the Wharton School and has been a visiting professor at both Nihon University in Tokyo and, in 2015, at Hebrew University in Jerusalem. He has authored several books including two international bestsellers marketed in more than 30 countries.